Crucell, SBL Vaccin AB deal

CRXL acquired SBL for E39.4 million ($50.5 million) in cash. The deal gives CRXL Dukoral, an oral vaccine to prevent cholera and travelers' diarrhea that had about E14 million ($16.6 million) in 2005...